Skip to main content

Table 2 Cox regression analyses of post-treatment antibodies and disease-free survival

From: Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

  HR 95% CI lower 95% CI upper P value
Arm B 0.234 0.05 1.87 0.06
Arm C 0.197 0.044 0.883 0.03
∆RI1 (A,B,C) 0.23 0.056 0.941 0.04
  1. Cox regression analysis. 1∆RI = change in antibody RI from pre- to post-treatment in all patients (N = 50). HR hazard ratio, CI confidence interval